TRCT
ESMC

Tower Research Capital (TRC)’s Escalon Medical Corp ESMC Stock Holding History

Tower Research Capital (TRC)’s Portfolio ESMC Stock Details ESMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-93
Closed – – 5539
2015
Q3 		$0 Sell
93
-201
-68% -$261 ﹤0.01% 5351
2015
Q2 		$0 Buy
+294
New +$408 ﹤0.01% 5482
2013
Q3 		– Sell
-282
Closed – – 5080
2013
Q2 		$0 Buy
+282
New +$336 ﹤0.01% 4024

Other funds holding ESMC

SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return

Tower Research Capital (TRC)'s ESMC Position: Q4 2015 in Review

Tower Research Capital (TRC) sold out of Escalon Medical Corp (ESMC) in Q4 2015, closing a stake of 93 shares.

Tower Research Capital (TRC) first reported a position in ESMC in Q2 2013 and held it in 3 quarters. The position peaked at $0 in Q3 2015. 14 funds tracked by Wall St. Rank hold ESMC as of Q4 2015.

  • Tower Research Capital (TRC) reported no remaining Escalon Medical Corp position as of Q4 2015 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 93 Escalon Medical Corp shares in Q4 2015.
  • Tower Research Capital (TRC) first reported a position in Escalon Medical Corp in Q2 2013 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s Escalon Medical Corp position peaked at $0 in Q3 2015.
  • 14 funds tracked by Wall St. Rank held Escalon Medical Corp as of Q4 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2015, filed 10 Feb 2016.